Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-42,300
Closed -$2.44M – 3651
2024
Q3
$2.44M Buy
42,300
+11,700
+38% +$632K 0.01% 1430
2024
Q2
$1.48M Sell
30,600
-4,200
-12% -$203K ﹤0.01% 1734
2024
Q1
$1.69M Buy
34,800
+28,700
+470% +$1.4M ﹤0.01% 1582
2023
Q4
$303K Buy
+6,100
New +$298K ﹤0.01% 3194

Other funds holding SNY

GTS Securities's SNY Position: Q2 2026 in Review

GTS Securities opened a new position in Sanofi (SNY) in Q2 2026: 18,059 shares worth $770K. The stake represents 0.02% of the portfolio and ranks #539 among its holdings. This is a return to the name: GTS Securities previously reported a position in SNY as recently as Q1 2025.

GTS Securities first reported a position in SNY in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.99M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • GTS Securities held 18,059 shares of Sanofi worth $770K as of Q2 2026.
  • Sanofi was a new GTS Securities position in Q2 2026.
  • Sanofi made up 0.02% of GTS Securities's portfolio in Q2 2026, its #539 holding.
  • GTS Securities first reported a position in Sanofi in Q2 2023 and has held it in 8 quarters since.
  • GTS Securities's Sanofi position peaked at $5.99M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.